Nova Eye Medical Limited
Nova Eye Medical Limited (ELXMF) Revenue
Annual & quarterly revenue history · segment & region breakdown
ELXMF · revenue · updated Jun 9, 2026
Core revenue metrics
Trailing 12 monthsNova Eye Medical Limited trailing twelve-month (TTM) revenue is $0.06B, an increase of 25.47% year-over-year from $0.03B in FY2025.
Revenue trend
2025 – 2006 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-06-30 | $0.03B | +$0.01B | +25.47% |
| 2024-06-30 | $0.02B | +$0.01B | +37.00% |
| 2023-06-30 | $0.02B | +$0.00B | +27.26% |
| 2022-06-30 | $0.01B | -$0.00B | -0.12% |
| 2021-06-30 | $0.01B | +$0.00B | +4.89% |
| 2020-06-30 | $0.01B | -$0.00B | -20.89% |
| 2019-06-30 | $0.02B | -$0.06B | -79.68% |
| 2018-06-30 | $0.08B | +$0.01B | +10.61% |
| 2017-06-30 | $0.07B | -$0.00B | -1.65% |
| 2016-06-30 | $0.07B | +$0.01B | +16.34% |
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Nova Eye Medical Limited receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Nova Eye Medical Limited reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in AUD.
Data sourced from Nova Eye Medical Limited's 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
ELXMF revenue · 4 questionsELXMF's trailing twelve-month (TTM) revenue is $0.06B. That is an increase of 25.47% year-over-year from $0.03B in FY2025.
▸ Source: FMP · Nova Eye Medical Limited SEC filings · GAAP · Nova Eye Medical Limited SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026